Immunotherapies for Malignant Glioma

por Boussiotis, Vassiliki A., Charest, Alain
Publicado 2017

Effects of PD-1 Signaling on Immunometabolic Reprogramming

por Boussiotis, Vassiliki A., Patsoukis, Nikolaos
Publicado 2022

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation

por Bardhan, Kankana, Anagnostou, Theodora, Boussiotis, Vassiliki A.
Publicado 2016

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies

por Karantanos, Theodoros, Politikos, Ioannis, Boussiotis, Vassiliki A
Publicado 2017

Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells

por Li, Lequn, Patsoukis, Nikolaos, Petkova, Victoria, Boussiotis, Vassiliki A.
Publicado 2012

Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2

por Christofides, Anthos, Karantanos, Theodoros, Bardhan, Kankana, Boussiotis, Vassiliki A.
Publicado 2016

Revisiting the PD-1 pathway

por Patsoukis, Nikolaos, Wang, Qi, Strauss, Laura, Boussiotis, Vassiliki A.
Publicado 2020

Commentary on: Combination of Metabolic Intervention and T Cell Therapy Enhances Solid Tumor Immunotherapy

por Christofides, Anthos, Tijaro-Ovalle, Natalia M., Boussiotis, Vassiliki A.
Publicado 2021

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases

por Ibis, Betul, Aliazis, Konstantinos, Cao, Carol, Yenyuwadee, Sasitorn, Boussiotis, Vassiliki A.
Publicado 2023

Regulation of T Cell Differentiation and Function by EZH2

por Karantanos, Theodoros, Christofides, Anthos, Bardhan, Kankana, Li, Lequn, Boussiotis, Vassiliki A.
Publicado 2016

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2

por Karantanos, Theodoros, Christofides, Anthos, Bardhan, Kankana, Li, Lequn, Boussiotis, Vassiliki A.
Publicado 2016

Metabolic Targets for Improvement of Allogeneic Hematopoietic Stem Cell Transplantation and Graft-vs.-Host Disease

por Tijaro-Ovalle, Natalia M., Karantanos, Theodoros, Wang, Hong-Tao, Boussiotis, Vassiliki A.
Publicado 2019

T Cell Metabolism in Cancer Immunotherapy

por Aksoylar, Halil-Ibrahim, Tijaro-Ovalle, Natalia M., Boussiotis, Vassiliki A., Patsoukis, Nikolaos
Publicado 2020

Clinical significance of T cell metabolic reprogramming in cancer

por Herbel, Christoph, Patsoukis, Nikolaos, Bardhan, Kankana, Seth, Pankaj, Weaver, Jessica D., Boussiotis, Vassiliki A.
Publicado 2016

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses

por Patsoukis, Nikolaos, Weaver, Jessica D., Strauss, Laura, Herbel, Christoph, Seth, Pankaj, Boussiotis, Vassiliki A.
Publicado 2017

The evolving role of tissue-resident memory T cells in infections and cancer

por Yenyuwadee, Sasitorn, Sanchez-Trincado Lopez, Jose Luis, Shah, Rushil, Rosato, Pamela C., Boussiotis, Vassiliki A.
Publicado 2022

Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells

por Barata, Joao T., Silva, Ana, Brandao, Joana G., Nadler, Lee M., Cardoso, Angelo A., Boussiotis, Vassiliki A.
Publicado 2004

Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy

por Le Bourgeois, Thibault, Strauss, Laura, Aksoylar, Halil-Ibrahim, Daneshmandi, Saeed, Seth, Pankaj, Patsoukis, Nikolaos, Boussiotis, Vassiliki A.
Publicado 2018

Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin αIIbβ3

por Watanabe, Naohide, Bodin, Laurent, Pandey, Manjula, Krause, Matthias, Coughlin, Shaun, Boussiotis, Vassiliki A., Ginsberg, Mark H., Shattil, Sanford J.
Publicado 2008

Structural, biochemical, and functional properties of the Rap1-Interacting Adaptor Molecule (RIAM)

por Sari-Ak, Duygu, Torres-Gomez, Alvaro, Yazicioglu, Yavuz-Furkan, Christofides, Anthos, Patsoukis, Nikolaos, Lafuente, Esther M., Boussiotis, Vassiliki A.
Publicado 2022